Integrated approach to study the dehydration kinetics of nitrofurantoin monohydrate

Journal of Pharmaceutical Sciences

Volumn 99, Issue 9, 2010, Pages 3966-3976

  Koradia, Vishal ^a   De Diego, Heidi Lopez ^b   Elema, Michiel Ringkjøbing ^b   Rantanen, Jukka ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b H LUNDBECK A S   (Denmark)

Author keywords

Dehydration; Hydrate; Nitrofurantoin; Solid state kinetics; Solid state stability; Thermogravimetric analysis; Transformation; X ray diffractometry

Indexed keywords

NITROFURANTOIN;

ARTICLE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STRUCTURE; MODEL; SOLID STATE; TEMPERATURE; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION;

EID: 77956370556     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22244     Document Type: Article

References (45)

1. Griesser UJ. 2006. The importance of solvates. In: Hilfiker R, editor. Polymorphism in the pharmaceutical industry. Weinheim: Willey-VCH Verlag GmbH & Co. pp 211-233.
2. Morris KR. 1999. Structural aspects of hydrates and solvates. In: Brittain HG, editor. Polymorphism in pharmaceutical solids. New York: Marcel Dekker, Inc. pp 125-182.
3. Brittain HG. 2008. Polymorphism and solvatomorphism 2006. J Pharm Sci 97:3611-3636.
4. Brittain HG. 2009. Polymorphism and solvatomorphism 2007. J Pharm Sci 98:1617-1642.
5. Byrn SR, Pfeiffer RR, Stowell JG. 1999. Solid-state chemistry of drugs, 2nd edition. West Lafayette, IN: SSCI, Inc. pp 233-247.
6. Garner WE. 1955. Chemistry of solid state. London: Butterworths Scientific Publications. pp 213-231.
7. Variankaval N, Lee C, Xu J, Calabria R, Tsou N, Ball R. 2007. Water activity-mediated control of crystalline phases of an active pharmaceutical ingredient. Org Process Res Dev 11:229-236.
8. Wikström H, Marsac PJ, Taylor LS. 2005. In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy. J Pharm Sci 94:209-219. (Pubitemid 40116384)
9. Sandler N, Rantanen J, Heinamaki J, Romer M, Marvola M, Yliruusi J. 2005. Pellet manufacturing by extrusion-spheronization using process analytical technology. AAPS PharmSciTech 6:E174-E182.
10. Hausman DS, Cambron RT, Sakr A. 2005. Application of online Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability. Int J Pharm 299:19-33.
11. Aaltonen J, Kogermann K, Strachan CJ, Rantanen J. 2007. In-line monitoring of solid-state transitions during fluidisation. Chem Eng Sci 62:408-415. (Pubitemid 44750896)
12. Leung SS, Padden BE, Munson EJ, Grant DJW. 1998. Solidstate characterization of two polymorphs of aspartame hemihydrate. J Pharm Sci 87:501-507.
13. Cavatur RK, Suryanarayanan R. 1998. Characterization of phase transitions during freeze-drying by in situ X-ray powder diffractometry. Pharm Dev Technol 3:579-586. (Pubitemid 28530356)
14. Higgins JP, Arrivo SM, Reed RA. 2003. Approach to the determination of hydrate form conversions of drug compounds and solid dosage forms by near-infrared spectroscopy. J Pharm Sci 92:2303-2316.
15. Jørgensen AC, Strachan CJ, Pollanen KH, Koradia V, Tian F, Rantanen J. 2009. An insight into water of crystallization during processing using vibrational spectroscopy. J Pharm Sci 98:3903-3932.
16. Sheng J, Venkatesh GM, Duddu SP, Grant DJ. 1999. Dehydration behavior of eprosartan mesylate dihydrate. J Pharm Sci 88:1021-1029.
17. Niazi S. 1978. Thermodynamics of mercaptopurine dehydration. J Pharm Sci 67:488-491.
18. Shefter E, Fung HL, Mok O. 1973. Dehydration of crystalline theophylline monohydrate and ampicillin trihydrate. J Pharm Sci 62:791-794.
19. Dong ZD, Salsbury JS, Zhou DL, Munson EJ, Schroeder SA, Prakash I, Vyazovkin S, Wight CA, Grant DJW. 2002. Dehydration kinetics of neotame monohydrate. J Pharm Sci 91:1423-1431.
20. Perrier PR, Byrn SR. 1982. Influence of crystal packing on the solid-state desolvation of purine and pyrimidine hydrates: Loss of water of crystallization from thymine monohydrate, cytosine monohydrate, 5-nitrouracil monohydrate, and 2′-deoxyadenosine monohydrate. J Org Chem 47:4671-4676.
21. Sheth AR, Zhou D, Muller FX, Grant DJ. 2004. Dehydration kinetics of piroxicam monohydrate and relationship to lattice energy and structure. J Pharm Sci 93:3013-3026.
22. Taylor LS, York P. 1998. Effect of particle size and temperature on the dehydration kinetics of trehalose dihydrate. Int J Pharm 167:215-221. (Pubitemid 28341523)
23. Zhou D, Schmitt EA, Zhang GGZ, Law D, Wight CA, Vyazovkin S, Grant DJW. 2003. Model-free treatment of the dehydration kinetics of nedocromil sodium trihydrate. 92:1367-1376.
24. Galwey AK, Koga N, Tanaka H. 1990. A kinetic and microscopic investigation of the thermal dehydration of lithium-sulfate monohydrate. J Chem Soc Faraday Trans 86:531-537.
25. Galwey AK. 2000. Structure and order in thermal dehydrations of crystalline solids. Thermochim Acta 355:181-238.
26. Petit S, Coquerel G. 1996. Mechanism of several solid-solid transformations between dihydrated and anhydrous copper(II) 8- hydroxyquinolinates. Proposition for a unified model for the dehydration of molecular crystals. Chem Mater 8:2247-2258.
27. Khawam A, Flanagan DR. 2006. Basics and applications of solid-state kinetics: A pharmaceutical perspective. J Pharm Sci 95:472-498.
28. Khawam A, Flanagan DR. 2006. Solid-state kinetic models: Basics and mathematical fundamentals. J Phys Chem B 110:17315-17328.
29. Agbada CO, York P. 1994. Dehydration of theophylline monohydrate powder - effects of particle-size and sample weight. Int J Pharm 106:33-40.
30. Vyazovkin S, Wight CA. 1999. Model-free and model-fitting approaches to kinetic analysis of isothermal and nonisothermal data. Thermochim Acta 341:53-68.
31. Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL. 2004. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm 1:85-96.
32. Caira MR, Pienaar EW, Lötter AP. 1996. Polymorphism and pseudopolymorphism of the antibacterial nitrofurantoin. Mol Cryst Liq Cryst 279:241-264.
33. Pienaar EW, Caira MR, Lötter AP. 1993. Polymorphs of nitrofurantoin. 1. Preparation and X-ray crystal-structures of two monohydrated forms of nitrofurantoin. J Crystallogr Spectr Res 23:739-744.
34. Pienaar EW, Caira MR, Lötter AP. 1993. Polymorphs of nitrofurantoin. 2. Preparation and X-ray crystal-structures of two anhydrous forms of nitrofurantoin. J Crystallogr Spectr Res 23:785-790.
35. Tian F, Baldursdóttir S, Rantanen J. 2009. Effects of polymer additives on the crystallization of hydrates: A molecular-level modulation. Mol Pharm 6:202-210.
36. Tian F, Qu H, Louhi-Kultanen M, Rantanen J. Crystallization of a polymorphic hydrate system. J Pharm Sci 99:753-763.
37. Wikström H, Rantanen J, Gift AD, Taylor LS. 2008. Toward an understanding of the factors influencing anhydrate-to-hydrate transformation kinetics in aqueous environments. Cryst Growth Des 8:2684-2693.
38. KarjalainenM, Airaksinen S, Rantanen J, Aaltonen J, Yliruusi J. 2005. Characterization of polymorphic solid-state changes using variable temperature X-ray powder diffraction. J Pharm Biomed Anal 39:27-32. (Pubitemid 41112115)
39. Kishi A, Otsuka M, Matsuda Y. 2002. The effect of humidity on dehydration behavior of nitrofurantoin monohydrate studied by humidity controlled simultaneous instrument for X-ray diffractometry and differential scanning calorimetry (XRDDSC). Colloids Surf B 25:281-291.
40. Khawam A, Flanagan DR. 2005. Role of isoconversional methods in varying activation energies of solid-state kinetics - I. Isothermal kinetic studies. Thermochim Acta 429:93-102.
41. Vyazovkin S, Wight CA. 1997. Kinetics in solids. Annu Rev Phys Chem 48:125-149.
42. Zhou DL, Grant DJW. 2004. Model dependence of the activation energy derived from nonisothermal kinetic data. J Phys Chem A 108:4239-4246.
43. Galwey AK, Laverty GM. 1990. The nucleus in solid-state reactions - Towards a definition. Solid State Ionics 38:155-162.
44. Nichols G. 2006. Light microscopy. In: Hilfiker R, editor. Polymorphism in the pharmaceutical industry. Weinheim: Willey-VCH Verlag GmbH & Co. pp 167-209.
45. Byrn SR, Lin CT. 1976. The effect of crystal packing and defects on desolvation of hydrate crystals of caffeine and L-(-)-1,4-cyclohexadiene-1- alanine. J Am Chem Soc 98:4004-4005.